Dr Gokhan Cildir

Research Interests

Autoimmunity Genetic Immunology Immunology Tumour Immunology

Dr Gokhan Cildir

Senior Research Fellow

Centre for Cancer Biology

Teaching Enterprise

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.

Date Position Institution name
2025 - ongoing Senior Research Fellow University of South Australia
2016 - 2024 Research Fellow University of South Australia

Date Type Title Institution Name Country Amount
2025 Award Best Post Doctorate Presentation Award Australian and New Zealand Society for Immunology Australia -
2025 Award Inaugural Emerging Leader Award Centre for Cancer Biology Australia -
2025 Award The Isil Berat Barlan Award in Primary Immunodeficiency Diseases The Turkish Society of Immunology Turkey -
2021 Award CUT&RUN Award Integrated Sciences Australia -
2020 Award Early Career Researcher Award Centre for Cancer Biology Australia -
2020 Award Best Research Publication Award Centre for Cancer Biology Australia -
2020 Award Artificial Intelligence Molecular Screen (AIMS) Award Atomwise United States -
2019 Award Young Investigator Award International Association of Inflammation Societies United Kingdom -
2019 Fellowship Early Career Fellowship The Hospital Research Foundation (THRF) Australia -
2019 Award Artificial Intelligence Molecular Screen (AIMS) Award Atomwise Australia -
2019 Award Travel Award European Mast Cell and Basophil Research Network Sweden -
2011 Scholarship Singapore International Graduate Award Agency for Science, Technology and Research Singapore -

Language Competency
English Can read, write, speak, understand spoken and peer review
Turkish Can read, write, speak, understand spoken and peer review

Date Institution name Country Title
2011 - 2016 National University of Singapore Singapore PhD
2006 - 2011 Izmir Institute of Technology Turkey BSc

Year Citation
2025 Bayram Catak, F., Catak, M. C., Babayeva, R., Toubia, J., Warnock, N. I., Kok, C. H., . . . Baris, S. (2025). Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease. Journal of Allergy and Clinical Immunology, 55(3), 784-791.
DOI Scopus3 WoS3 Europe PMC3
2025 Bozkurt, C., Cildir, G., Aba, U., Erdogan, R. K., Warnock, N. I., Kok, C. H., & Erman, B. (2025). Comprehensive αβ T-Cell receptor repertoire analysis reveals a unique CD8 TCR landscape in DOCK8-deficient patients. Allergy, online(9), 1-12.
DOI
2025 Tedesco, L., Ali, S. B., Erman, B., Baris, S., Pant, H., Hissaria, P., . . . Cildir, G. (2025). IgG4-Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets. Allergy. European Journal of Allergy and Clinical Immunology, 80(10), 2738-2754.
DOI Scopus1 WoS1
2024 Wang, H., Yip, K. H., Keam, S. P., Vlahos, R., Nichol, K., Wark, P., . . . Tumes, D. J. (2024). Dual inhibition of airway inflammation and fibrosis by common β cytokine receptor blockade. Journal of Allergy and Clinical Immunology, 153(3), 672-683.e6.
DOI Scopus8 WoS8 Europe PMC8
2024 Aba, Ü., Maslak, İ. C., İpşir, C., Pehlivan, D., Warnock, N. I., Tumes, D. J., . . . Erman, B. (2024). A novel homozygous germline mutation in transferrin receptor 1 (TfR1) leads to combined immunodeficiency and provides new insights into iron-immunity axis. Journal of Clinical Immunology, 44(2, article no. 55), 1-14.
DOI Scopus8 WoS10 Europe PMC7
2024 Wallach, I., Bernard, D., Nguyen, K., Ho, G., Tumes, D., Cildir, G., & Heifets, A. (2024). AI is a viable alternative to high throughput screening: a 318-target study. Scientific Reports, 14(1), 1-16.
DOI Scopus64 WoS70 Europe PMC68
2024 Cildir, G., Aba, U., Pehlivan, D., Tvorogov, D., Warnock, N. I., Ipsir, C., . . . Erman, B. (2024). Defective kinase activity of IKKα leads to combined immunodeficiency and disruption of immune tolerance in humans. Nature Communications, 15(1), 9944-1-9944-18.
DOI Scopus1 WoS1 Europe PMC1
2024 Erman, B., Aba, U., Ipsir, C., Pehlivan, D., Cildir, G., & Tezcan, I. (2024). Genetic evaluation of the patients with clinically diagnosed inborn errors of immunity by whole exome sequencing: results from a specialized research center for immunodeficiency in Türkiye. Journal of Clinical Immunology, 44(7, article no. 157), 1-19.
DOI
2023 Conn, V. M., Gabryelska, M., Toubia, J., Kirk, K., Gantley, L., Powell, J. A., . . . Conn, S. J. (2023). Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia. Cancer Cell, 41(7), 1309-1326.e10.
DOI Scopus51 WoS50 Europe PMC47
2021 De Silva, A. P., Schembri, M. A., Sarah, A. H., Chao, J., Yip, K. H., Cildir, G., . . . Pant, H. (2021). Short-term oral steroids significantly improves chronic rhinosinusitis without nasal polyps. Laryngoscope, 131(10), E2618-E2626.
DOI Scopus6 WoS6 Europe PMC4
2021 Oksdath Mansilla, M., Salazar-Hernandez, C., Perrin, S. L., Scheer, K. G., Cildir, G., Toubia, J., . . . Gomez, G. A. (2021). 3D-printed microplate inserts for long term high-resolution imaging of live brain organoids. BMC biomedical engineering, 3(6), 1-14.
DOI Europe PMC17
2021 Cildir, G., Yip, K. H., Pant, H., Tergaonkar, V., Lopez, A. F., & Tumes, D. J. (2021). Understanding mast cell heterogeneity at single cell resolution. Trends in Immunology, 42(6), 523-535.
DOI Scopus32 WoS29 Europe PMC29
2021 Cildir, G., & Tumes, D. J. (2021). DOT1L leaves its mark on adaptive immunity. Immunology and Cell Biology, 99(4), 348-350.
DOI
2021 Gutierrez, S., Fischer, J., Ganesan, R., Judith, N. H., Cildir, G., Wolke, M., . . . Robinson, N. (2021). Salmonella Typhimurium impairs glycolysismediated acidification of phagosomes to evade macrophage defense. PLoS Pathogens, 17(9), 26 pages.
DOI Scopus25 WoS23 Europe PMC26
2019 Fischer, J., Gutièrrez, S., Ganesan, R., Calabrese, C., Ranjan, R., Cildir, G., . . . Robinson, N. (2019). Leptin signaling impairs macrophage defenses against Salmonella Typhimurium. Proceedings of the National Academy of Sciences of the United States of America, 116(33), 16551-16560.
DOI Scopus22 WoS21 Europe PMC23
2019 Cildir, G., Toubia, J., Yip, K. H., Zhou, M., Pant, H., Hissaria, P., . . . Tergaonkar, V. (2019). Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases. Immunity, 51(5), 949-965.
DOI Scopus48 WoS49 Europe PMC48
2019 Khattar, E., Maung, K. Z. Y., Chew, C. L., Ghosh, A., Cildir, G., & Tergaonkar, V. (2019). Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy. Nature Communications, 10(1, article no. 5349), 1-14.
DOI
2018 Maung, K. Z. Y., Leo, P. J., Bassal, M., Casolari, D. A., Gray, J. X., Bray, S. C., . . . Gonda, T. J. (2018). Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia. Blood Cancer Journal, 8(6), 50-1-50-5.
DOI Scopus16 WoS16 Europe PMC13
2017 Cildir, G., Pant, H., Lopez, A., & Tergaonkar, V. (2017). The transcriptional program, functional heterogeneity, and clinical targeting of mast cells. Journal of Experimental Medicine, 214(9), 2491-2506.
DOI Scopus84 WoS79 Europe PMC73
2017 Conn, V. M., Hugouvieux, V., Nayak, A., Conos, S. A., Capovilla, G., Cildir, G., . . . Conn, S. J. (2017). A circRNA from SEPALLATA3 regulates splicing of its cognate mRNA through R-loop formation. Nature plants, 3(17053), 1-5.
DOI
2016 Cildir, G., Low, K. C., & Tergaonkar, V. (2016). Noncanonical NF-κB signaling in health and disease. Trends in molecular medicine, 22(5), 414-429.
DOI
2013 Cildir, G., Akincilar, S. C., & Tergaonkar, V. (2013). Chronic adipose tissue inflammation: all immune cells on the stage. Trends in molecular medicine, 19(8), 487-500.
DOI

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Mrs Zahra Esmaeili
2025 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Ms Louisa Marie Tedesco
2024 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Ms Anita Kral

Date Role Committee Institution Country
2025 - ongoing Member IES Early Career Committee International Eosinophil Society United States

Date Role Membership Country
2025 - ongoing Member Clinical Immunogenomics Research Consortium Australasia (CIRCA) -
2025 - ongoing Member Australasian Society of Clinical Immunology and Allergy (ASCIA) -

Date Title Engagement Type Institution Country
2025 - ongoing Medical and Scientific Advisory Panel Member Scientific Community Engagement Australian Primary Immunodeficiency Patient Support (AusPIPS Inc) -

Connect With Me

External Profiles

Other Links